Altered blood pressure response to propyldazine after repeated oral administration in conscious normotensive dogs: role of the renin-angiotensin system
- 1 September 1984
- journal article
- research article
- Published by Springer Nature in Basic Research in Cardiology
- Vol. 79 (5) , 588-597
- https://doi.org/10.1007/bf01910488
Abstract
The magnitude and the persistence of blood pressure reduction by propyldazine (PDZ) was investigated following treatment over a period of 4 days. The experiments were performed on 6 normotensive dogs trained to submit to puncture of the femoral artery and to stand quietly in a special frame over the experimental period of 7 to 8 hours. The first dose effect of orally administered PDZ (0.06, 0.29 and 1.42 mg/kg) on heart rate, arterial blood pressure and plasma renin activity (PRA) was compared with the fffect of the substance after treatment at the same respective dosage twice daily over 4 days. The compound caused a dosedependent decrease in blood pressure accompained by dose-dependent increases in heart rate and PRA. With 0.06 mg/kg and 0.29 mg/kg PDZ a sustained effect on arterial blood pressure was observed, whereas with 1.42 mg/kg PDZ tolerance occurred after treatment over the 4-day period. A comparison with the effects observed previously with 1.42 and 7.1 mg/kg dihydralazine (DHZ) under identical conditions showed similar results with respect to dose-dependence of blood pressure and counterregulation (1). It is considered that with a low-doseregimen there would be no decrease in activity of PDZ, the long-term hypotensive efficacy of the drug thereby being guaranteed.This publication has 22 references indexed in Scilit:
- Blood pressure response and renin release following 4 days of treatment with dihydralazine and urapidil in conscious dogsCardiovascular Research, 1984
- Hydralazine in the long-term treatment of chronic heart failure: Lack of difference from placeboAmerican Heart Journal, 1982
- Changes in Control of Renin Release in Congestive Heart Failure in Dogs: Response to Acute and Chronic Vasodilator TherapyClinical and Experimental Hypertension. Part A: Theory and Practice, 1982
- Determinants of drug response in severe chronic heart failure. 1. Activation of vasoconstrictor forces during vasodilator therapy.Circulation, 1981
- Hydralazine and related compounds: Chemistry, metabolism, and mode of actionMedicinal Research Reviews, 1981
- Synthesis and antihypertensive properties of new 3-hydrazinopyridazine derivativesJournal of Medicinal Chemistry, 1975
- Altered renin release and propranolol potentiation of vasodilatory drug hypotension.Journal of Clinical Investigation, 1975
- Alterations in the Baroreceptor Reflex in Conscious Dogs with Heart FailureJournal of Clinical Investigation, 1972
- Combined Therapy with Vasodilator Drugs and Beta-Adrenergic Blockade in HypertensionCirculation, 1972
- Relationship of extracellular fluid volume to the development of drug resistance in the hypertensive patientAmerican Heart Journal, 1971